-
Re: A2 20 Nov 201320/11/13 at 12:162013-11-20 12:16:20
Marcel Llanca N. -
Re: A2 20 Nov 201320/11/13 at 12:142013-11-20 12:14:20
Paloma A. Muñoz -
Re: A2 20 Nov 201320/11/13 at 12:112013-11-20 12:11:20
Samuel Fernández Sandoval -
Re: A2 20 Nov 201320/11/13 at 12:092013-11-20 12:09:20
Marcel Llanca N. -
Re: A2 20 Nov 201320/11/13 at 12:062013-11-20 12:06:20
Daniela Mardones Vega -
Re: A2 20 Nov 201320/11/13 at 12:012013-11-20 12:01:20
Marco Arratia Peirano -
Re: A2 20 Nov 201320/11/13 at 11:542013-11-20 11:54:20
Samuel Fernández Sandoval -
Re: A2 20 Nov 201320/11/13 at 11:502013-11-20 11:50:20
Marcel Llanca N. -
Re: A2 20 Nov 201320/11/13 at 11:472013-11-20 11:47:20
Marco Arratia Peirano -
Re: A2 20 Nov 201320/11/13 at 11:322013-11-20 11:32:20
Fabián Cid Cruz -
Re: A2 20 Nov 201320/11/13 at 11:162013-11-20 11:16:20
Marcel Llanca N. -
Re: A2 20 Nov 201320/11/13 at 10:532013-11-20 10:53:20
Samuel Fernández Sandoval -
Re: A2 20 Nov 201320/11/13 at 10:382013-11-20 10:38:20
Marcel Llanca N. -
Clase Farmacos ansiolítios e hipnóticos y Antimaniacos.zip 19 Nov 201319/11/13 at 20:532013-11-19 20:53:19
Karol Mora M. -
Control 4 19 Nov 201319/11/13 at 08:502013-11-19 08:50:19
Ernesto González A.
-
Control 3 19 Nov 201319/11/13 at 08:242013-11-19 08:24:19
Ernesto González A.
-
Re: A2 18 Nov 201318/11/13 at 20:262013-11-18 20:26:18
Samuel Fernández Sandoval -
Re: A2 18 Nov 201318/11/13 at 18:232013-11-18 18:23:18
Marcel Llanca N. -
Re: A2 18 Nov 201318/11/13 at 18:202013-11-18 18:20:18
Bárbara Figueroa F. -
Re: A2 18 Nov 201318/11/13 at 18:192013-11-18 18:19:18
Marcel Llanca N. -
Re: A2 17 Nov 201317/11/13 at 20:472013-11-17 20:47:17
Valeria S. Zagal
-
Re: A2 17 Nov 201317/11/13 at 18:132013-11-17 18:13:17
Samuel Fernández Sandoval -
Re: A2 17 Nov 201317/11/13 at 15:372013-11-17 15:37:17
Mario Esteban Allende S. -
Re: A2 16 Nov 201316/11/13 at 17:472013-11-16 17:47:16
Samuel Fernández Sandoval -
A2 16 Nov 201316/11/13 at 17:152013-11-16 17:15:16
Samuel Fernández Sandoval